Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma
Clinical trial NCT05122091 · UNKNOWN
Trial details
- NCT number
- NCT05122091
- Sponsor
- Guangxi Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2024-11-05
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.